Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
Plasma Processes and Polymers (Print)|February 1, 2023
Oral SARS-CoV-2 reduction by local treatment: A plasma technology application?Thomas von Woedtke, Gülsah Gabriel, Ulrich E Schaible, et al.Cellular Microbiology|February 1, 2012
Interaction of influenza A virus matrix protein with RACK1 is required for virus releaseDimiter Demirov, Gülsah Gabriel, Carola Schneider, et al.Research in Veterinary Science|September 11, 2023
Distribution of importin-α isoforms in poultry species and their tissue- and age-related differencesAlexandra Herbst, Frederik Bexter, Nancy Mounogou Kouassi, et al.Plos One|March 31, 2022
Pre-existing helminth infection impairs the efficacy of adjuvanted influenza vaccination in miceWiebke Hartmann, Marie-Luise Brunn, Nadine Stetter, et al.The Journal of General Virology|November 13, 2015
PB2 subunit of avian influenza virus subtype H9N2: a pandemic risk factorHanna Sediri, Swantje Thiele, Folker Schwalm, et al.The American Journal of Pathology|June 28, 2011
Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse modelsAnna Otte, Martina Sauter, Lisa Alleva, et al.Vaccine|August 31, 2015
Sex differences in H7N9 influenza A virus pathogenesisJulia Hoffmann, Anna Otte, Swantje Thiele, et al.Antiviral Research|February 4, 2014
A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachmentJulia Hoffmann, Carola Schneider, Lena Heinbockel, et al.Journal of Virology|June 6, 2014
PB2 mutations D701N and S714R promote adaptation of an influenza H5N1 virus to a mammalian hostVolker Czudai-Matwich, Anna Otte, Mikhail Matrosovich, et al.Journal of Virology|November 16, 2018
A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy ModelCindy Nürnberger, Bianca S Bodmer, Anna H Fiedler, et al.Pageof 7